Wikidata

(Q44195752)

English

A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.

scientific article published in August 2003

In more languages

Statements

title
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
14518696
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14518696%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44195752&oldid=2108420735"